Gracell Biotechnologies Inc GRCL:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EDT
12.80quote price arrow down-0.10 (-0.78%)
Volume
43,620
52 week range
12.30 - 33.70

...

Loading . . .
  • Open13.12
  • Day High13.25
  • Day Low12.41
  • Prev Close12.90
  • 52 Week High33.70
  • 52 Week High Date02/04/21
  • 52 Week Low12.30
  • 52 Week Low Date04/06/21

Key Stats

  • Market Cap167.81M
  • Shares Out13.11M
  • 10 Day Average Volume0.12M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-

KEY STATS

  • Open13.12
  • Day High13.25
  • Day Low12.41
  • Prev Close12.90
  • 52 Week High33.70
  • 52 Week High Date02/04/21
  • 52 Week Low12.30
  • 52 Week Low Date04/06/21
  • Market Cap167.81M
  • Shares Out13.11M
  • 10 Day Average Volume0.12M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.44
  • P/E (TTM)-29.08
  • Fwd P/E (NTM)-10.73
  • EBITDA (MRQ)-24.73M
  • ROE (MRQ)-
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)24.60%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Gracell Biotechnologies Inc

There is no recent news for this security.

Profile

MORE
Gracell Biotechnologies Inc is a China-based clinical-stage biopharmaceutical company focused on discovering and developing cell therapies for the treatment of cancers. The Company is primarily focused on disrupting conventional approaches to chimeric antigen receptor (CAR) thymus (T) cell therapies by leveraging its technology platforms FasTCAR and TruUCAR. With FasTCAR, the Company is able to deliver younger, less exhausted T cells for autologous cell therapies with...
Address
Building 3
418 Guilin Road, Xuhui District
Shanghai, SHA
200030
China